The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors
Open accessAbstract
The role of the gluco-incretin hormones GIP and GLP-1 in the control of beta cell function was studied by analyzing mice with inactivation of each of these hormone receptor genes, or both. Our results demonstrate that glucose intolerance was additively increased during oral glucose absorption when both receptors were inactivated. After intraperitoneal injections, glucose intolerance was more severe in double- as compared to single-receptor KO mice, and euglycemic clamps revealed normal insulin sensitivity, suggesting a defect in insulin secretion. When assessed in vivo or in perfused pancreas, insulin secretion showed a lack of first phase in Glp-1R(-/-) but not in Gipr(-/-) mice. In perifusion experiments, however, first-phase insulin secretion was present in both types of islets. In double-KO islets, kinetics of insulin secretion was normal, but its amplitude was reduced by about 50% because of a defect distal to plasma membrane depolarization. Thus, gluco-incretin hormones control insulin secretion (a) by an acute insulinotropic effect on beta cells after oral glucose absorption (b) through the regulation, by GLP-1, of in vivo first-phase insulin secretion, probably by an action on extra-islet glucose sensors, and (c) by preserving the function of the secretory pathway, as evidenced by a beta cell autonomous secretion defect when both receptors are inactivated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduced incretin effect in Type 2 (non-insulin dependent) diabetes
Nauck, M., Stöckmann, F., Ebert, R., & Creutzfeldt, W. (1986) · Diabetologia · doi:10.1007/bf02427280 · Cited by 1,307
Zander, M., Madsbad, S., Madsen, J. L., & Holst, J. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07952-7 · Cited by 1,297
Xu, G., Stoffers, D. A., Habener, J. F., & Bonner-Weir, S. (1999) · Diabetes · doi:10.2337/diabetes.48.12.2270 · Cited by 1,209
Inhibition of gastric inhibitory polypeptide signaling prevents obesity
Miyawaki, K., Yamada, Y., Ban, N., Ihara, Y., Tsukiyama, K., Zhou, H., Fujimoto, S., Oku, A., Tsuda, K., Toyokuni, S., et al. (2002) · Nature Medicine · doi:10.1038/nm727 · Cited by 963 · cited 10×
“We have demonstrated that the function of this sensor is suppressed when the GLP-1 receptor is absent, as in Glp-1R–/– mice or when inactivated by the antagonist exendin-(9-39).”
BackgroundMethodInfluentialThorens, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8641 · Cited by 906
Self-citationDrucker, D. J., Philippe, J., Mojsov, S., Chick, W. L., & Habener, J. F. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.10.3434 · Cited by 903 · cited 9×
“We have demonstrated that the function of this sensor is suppressed when the GLP-1 receptor is absent, as in Glp-1R–/– mice or when inactivated by the antagonist exendin-(9-39).”
BackgroundMethodSelf-citationMojsov, S., Weir, G. C., & Habener, J. F. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112855 · Cited by 882
Gutniak, M., Ørkov, C., Holst, J. J., Ahrén, B., & Efendić, S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262003 · Cited by 868
Scrocchi, L. A., Brown, T. J., Maclusky, N., Brubaker, P. L., Auerbach, A. B., Joyner, A. L., & Drucker, D. J. (1996) · Nature Medicine · doi:10.1038/nm1196-1254 · Cited by 793
Self-citationDisruption of the p70s6k/p85s6k gene reveals a small mouse phenotype and a new functional S6 kinase
Shima, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6649 · Cited by 636
Glucagon-like Peptide-1 Receptor Signaling Modulates β Cell Apoptosis
Li, Y., Hansotia, T., Yusta, B., Ris, F., Halban, P. A., & Drucker, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209423200 · Cited by 589
Self-citationStoffers, D. A., Kieffer, T. J., Hussain, M. A., Drucker, D. J., Bonner-Weir, S., Habener, J. F., & Egan, J. M. (2000) · Diabetes · doi:10.2337/diabetes.49.5.741 · Cited by 576
Self-citationcAMP promotes pancreatic β-cell survival via CREB-mediated induction of IRS2
Jhala, U. S., Canettieri, G., Screaton, R. A., Kulkarni, R. N., Krajewski, S., Reed, J., Walker, J., Lin, X., White, M., & Montminy, M. (2003) · Genes & Development · doi:10.1101/gad.1097103 · Cited by 543
Usdin, T. B., Mezey, E., Button, D. C., Brownstein, M. J., & Bonner, T. I. (1993) · Endocrinology · doi:10.1210/endo.133.6.8243312 · Cited by 534
cAMP-GEFII is a direct target of cAMP in regulated exocytosis
Ozaki, N., Shibasaki, T., Kashima, Y., Miki, T., Takahashi, K., Ueno, H., Sunaga, Y., Yano, H., Matsuura, Y., Iwanaga, T., et al. (2000) · Nature Cell Biology · doi:10.1038/35041046 · Cited by 481 · cited 2×
“The second messenger cAMP acts via two pathways in β cells: first, by activation of protein kinase A, which phosphorylates GLUT2, the KATP and Ca2+ channels (38–40), and as yet unidentified substrates; and second, by binding to the cAMP sensor protein cAMPGEF2 or Epac2, which forms a complex with Rim2 and activates Ra…”
BackgroundMiyawaki, K., Yamada, Y., Yano, H., Niwa, H., Ban, N., Ihara, Y., Kubota, A., Fujimoto, S., Kajikawa, M., Kuroe, A., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14843 · Cited by 454
Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2
Guillam, M.-T., Hümmler, E., Schaerer, E., Wu, J.-Y., Birnbaum, M. J., Beermann, F., Schmidt, A., Dériaz, N., & Thorens, B. (1997) · Nature Genetics · doi:10.1038/ng1197-327 · Cited by 431
Self-citationCritical Role of cAMP-GEFII·Rim2 Complex in Incretin-potentiated Insulin Secretion
Kashima, Y., Miki, T., Shibasaki, T., Ozaki, N., Miyazaki, M., Yano, H., & Seino, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108378200 · Cited by 381
Tourrel, C., Bailbe, D., Lacorne, M., Meile, M.-J., Kergoat, M., & Portha, B. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1443 · Cited by 285
Glucagonlike Peptide I (7–37) Actions on Endocrine Pancreas
Weir, G. C., Mojsov, S., Hendrick, G. K., & Habener, J. F. (1989) · Diabetes · doi:10.2337/diab.38.3.338 · Cited by 275
MacDonald, P. E., & Wheeler, M. B. (2003) · Diabetologia · doi:10.1007/s00125-003-1159-8 · Cited by 263
Burcelin, R., Da Costa, A., Drucker, D., & Thorens, B. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1720 · Cited by 250
Self-citationGOTOH, M., MAKI, T., SATOMI, S., PORTER, J., BONNER-WEIR, S., OʼHARA, C. J., & MONACO, A. P. (1987) · Transplantation · doi:10.1097/00007890-198705000-00024 · Cited by 218
Glucose sensing by the hepatoportal sensor is GLUT2-dependent: in vivo analysis in GLUT2-null mice.
Burcelin, R., Dolci, W., & Thorens, B. (2000) · Diabetes · doi:10.2337/diabetes.49.10.1643 · Cited by 209
Self-citationPortal GLP-1 administration in rats augments the insulin response to glucose via neuronal mechanisms
Balkan, B., & Li, X. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.279.4.r1449 · Cited by 200
Thorens, B., Guillam, M.-T., Beermann, F., Burcelin, R., & Jaquet, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002908200 · Cited by 185
Self-citationBeguin, P. (1999) · The EMBO Journal · doi:10.1093/emboj/18.17.4722 · Cited by 181
Gut hormones and diabetes mellitus
Creutzfeldt, W., & Nauck, M. (1992) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610080206 · Cited by 176
Therapy of type 2 diabetes mellitus based on the actions of glucagon‐like peptide‐1
Holst, J. J. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.328 · Cited by 169
Identification and Characterization of Glucoresponsive Neurons in the Enteric Nervous System
Liu, M., Seino, S., & Kirchgessner, A. L. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-23-10305.1999 · Cited by 167
Pederson, R. A., Satkunarajah, M., McIntosh, C. H., Scrocchi, L. A., Flamez, D., Schuit, F., Drucker, D. J., & Wheeler, M. B. (1998) · Diabetes · doi:10.2337/diabetes.47.7.1046 · Cited by 167
Self-citationGremlich, S., Porret, A., Hani, E. H., Cherif, D., Vionnet, N., Froguel, P., & Thorens, B. (1995) · Diabetes · doi:10.2337/diab.44.10.1202 · Cited by 166
Self-citationGomez, E., Pritchard, C., & Herbert, T. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209165200 · Cited by 162
Burcelin, R., Dolci, W., & Thorens, B. (2000) · Diabetes · doi:10.2337/diabetes.49.10.1635 · Cited by 137 · cited 10×
“We have demonstrated that the function of this sensor is suppressed when the GLP-1 receptor is absent, as in Glp-1R–/– mice or when inactivated by the antagonist exendin-(9-39).”
BackgroundMethodInfluentialSelf-citationThe pathogenesis of NIDDM involves a defective expression of the GIP receptor
Holst, J. J., Gromada, J., & Nauck, M. A. (1997) · Diabetologia · doi:10.1007/s001250050779 · Cited by 136
Pamir, N., Lynn, F. C., Buchan, A. M. J., Ehses, J., Hinke, S. A., Pospisilik, J. A., Miyawaki, K., Yamada, Y., Seino, Y., McIntosh, C. H. S., et al. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00270.2002 · Cited by 126
Gastrointestinal peptides and insulin secretion
Ebert, R., & Creutzfeldt, W. (1987) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610030101 · Cited by 99
Nishizawa, M., Nakabayashi, H., Uchida, K., Nakagaw, A., & Niijima, A. (1996) · Journal of the Autonomic Nervous System · doi:10.1016/s0165-1838(96)00071-9 · Cited by 96
Wang, Y., Egan, J., Raygada, M. J., Nadiv, O., Roth, J., & Montrose‐Rafizadeh, C. (1995) · Endocrinology · doi:10.1210/endo.136.11.7588224 · Cited by 91
Burcelin, R., Crivelli, V., Perrin, C., Costa, A. D., Mu, J., Kahn, B. B., Birnbaum, M. J., Kahn, C. R., Vollenweider, P., & Thorens, B. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16888 · Cited by 77
Self-citationProtein Kinase A-dependent Phosphorylation of GLUT2 in Pancreatic β Cells
Thorens, B., Dériaz, N., Bosco, D., DeVos, A., Pipeleers, D., Schuit, F. C., Meda, P., & Porret, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.14.8075 · Cited by 74
Self-citationFlamez, D., Breusegem, A. V., Scrocchi, L. A., Quartier, E., PIPELEERS, D. G., Drucker, D. J., & Schuit, F. C. (1998) · Diabetes · doi:10.2337/diabetes.47.4.646 · Cited by 71
Self-citationImplication of Glutamate in the Kinetics of Insulin Secretion in Rat and Mouse Perfused Pancreas
Maechler, P., Gjinovci, A., & Wollheim, C. B. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s99 · Cited by 61
Self-citationLeiser, M., & Fleischer, N. (1996) · Diabetes · doi:10.2337/diab.45.10.1412 · Cited by 41
Modulation of voltage-gated K+ channels Kv1.1 and Kv1.4 by forskolin
Matthias, K., Seifert, G., Reinhardt, S., & Steinhäuser, C. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00115-6 · Cited by 14
Leiser, M., & Fleischer, N. (1996) · Diabetes · doi:10.2337/diabetes.45.10.1412 · Cited by 11
Research works printed but not linked: 8
- 10.2337/diabetes.38.3.338 · DOI
- 10.1210/en.133.6.2861 · DOI · Paper page
- 10.1210/en.136.11.4910 · doi:10.1210/en.136.11.4910
- Burcelin, 2003, J. Clin. Invest., 111, 1555, 10.1172/JCI200316888 · DOI
- 10.2337/diabetes.44.10.1202 · DOI
- 10.1093/emboj/17.22.6649 · DOI · Paper page
- Balkan, 2000, Am. J. Physiol., 279, R1449
- Woodford, 1989, J. Biol. Chem., 264, 13321, 10.1016/S0021-9258(18)51631-8 · doi:10.1016/s0021-9258(18)51631-8
Cited by
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
The biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210
Self-citationGlucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
Self-citationBan, K., Noyan-Ashraf, M. H., Hoefer, J., Bolz, S.-S., Drucker, D. J., & Husain, M. (2008) · Circulation · doi:10.1161/circulationaha.107.739938 · Cited by 1,057
Self-citationPancreatic regulation of glucose homeostasis.
Röder, P. V., Wu, B., Liu, Y., & Han, W. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.6 · Cited by 985
Metadata
- Authors
- Preitner, F., Ibberson, M., Franklin, I., Binnert, C., Pende, M., Gjinovci, A., Hansotia, T., Drucker, D. J., Wollheim, C., Burcelin, R., & Thorens, B.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-02-15
- Volume
- 113
- Issue
- 4
- Pages
- 635-645
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2142414068
- Cited by
- 256
- References
- 46
- FWCI
- 16.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.